To address the functional role of CK2 in Ikaros and SHIP1 regulation in B-ALL, SupB15 and Reh cells were treated with the CK2 inhibitor CX4945 (Fig. 6B). This evidence concerns the gene IKZF1 and precursor B-cell acute lymphoblastic leukemia.